Linked Life Data

17507322

Source:http://linkedlifedata.com/resource/pubmed/id/17507322

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-5-17
pubmed:abstractText
To predict the decrease in progression to AIDS or death based on the treatment benefit of etravirine over active control on CD4 counts and HIV RNA.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1528-4336
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-76
pubmed:meshHeading
pubmed:articleTitle
Modelling-based prediction of clinical benefits from etravirine in the TMC125-C223 trial.
pubmed:affiliation
Pharmacology Laboratories, Liverpool University, UK. ahill1@tibbe.jnj.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase II, Meta-Analysis